Skip to content
Visit specialist site
Clinical specialist

David Waldenhjort, MD, Lic

Specialist in Internal Medicine and Cardiovascular Diseases · Executive HealthCardiovascular medicine, internal medicine, atrial fibrillation, echocardiography, anticoagulation

Heart rhythm and vascular assessment inside a full-body preventive screening, from a cardiology specialist who publishes on catching atrial fibrillation

BookView the practiceSource profileCredentials checked
Portrait of David Waldenhjort, MD

At a glance

Visit type
In person
Years in practice
22
Languages
Swedish, English

Practice

About

David Waldenhjort, MD is a specialist in internal medicine and cardiovascular diseases with Executive Health, the Swedish preventive screening company, and a senior consultant at the heart clinic of Ersta sjukhus in Stockholm. His research ran through the Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, the group behind much of Sweden's work on screening for atrial fibrillation. He took a licentiate degree there in 2014 with a thesis asking whether echocardiography can predict atrial fibrillation in patients who already have heart failure or have had a stroke, a question he had been publishing on since 2009.

Approach

Signature approach

Waldenhjort looks for the arrhythmia before it announces itself. His published work took 174 stroke and TIA patients with no known atrial fibrillation, imaged the heart with tissue Doppler echocardiography, then monitored the rhythm for 30 days. The imaging markers separated the 15 who turned out to have it. Structure first, then rhythm, then the treatment decision that follows.

What sets them apart

  • His research is cited in clinical guidance. The 2016 echocardiography paper he first-authored is cited by the European Stroke Organisation guideline on screening for atrial fibrillation after stroke, and by the AF-SCREEN International Collaboration white paper in Circulation.
  • A national-register role in anticoagulation. At Ersta sjukhus he is the physician responsible for dosing under Auricula, Sweden's national atrial fibrillation and anticoagulation register.
  • The clinic's technology voice. Five of the six articles in Executive Health's Technology & Innovation library carry his review, covering AI, wearables and stem cells.

Focus

Specialties

Cardiovascular Longevity

Who they see

Executives & High Performers

Conditions treated

  • Irregular heartbeat
    Atrial fibrillation
  • Heart failure
    Congestive heart failure
  • Stroke risk coming from the heart
    Ischaemic stroke and transient ischaemic attack of cardiac origin
  • Blood-thinner dosing
    Oral anticoagulation management

Training

Education

  • Licentiate degree (licentiatexamen), Medicine: atrial fibrillation, cardiac function and structure
    Karolinska Institutet (2014)

Board certifications

  • Specialist in Internal Medicine and Cardiovascular Diseases

    Socialstyrelsen (Swedish National Board of Health and Welfare)

    Swedish specialist competence in internal medicine and in cardiology, published by Executive Health as one credential line. Corroborated by his own peer-reviewed papers, which carry Department of Clinical Sciences and Department of Medicine affiliations from 2008 onward, and by an Ersta sjukhus patient document that titles him överläkare (senior consultant) and names him the physician responsible for anticoagulation dosing at the heart clinic. Employer-published and register-unverified: Socialstyrelsen is the sole issuer of Swedish specialist competence, and its register of licensed clinicians has no public online lookup, so no certificate number or date is confirmable and none is claimed.

Protocols

  • Echocardiography with tissue doppler imaging
  • Left atrial volume and function measurement
  • Ambulatory ecg rhythm screening
  • Oral anticoagulation dosing via the auricula national register

Published work

Elsewhere

Media and talks

Collaboration

  • Ersta sjukhus, Stockholm
    Senior consultant at the heart clinic and the physician responsible for anticoagulation dosing under the Auricula national register; documented 2016, 2020 and 2024 to 2025
  • Hans Persson, Karolinska Institutet
    Supervisor of his 2014 licentiate thesis at Danderyd Hospital and senior author on both of his peer-reviewed papers
  • Marten Rosenqvist, Karolinska Institutet
    Co-author on both papers, from the Danderyd group behind Sweden's atrial fibrillation screening research
  • Johan Engdahl, Karolinska Institutet
    Co-author on the 2016 study screening stroke and TIA patients for undiagnosed atrial fibrillation
  • Ruha Cerrato, Ersta sjukhus
    Principal supervisor on an Ersta heart-clinic pilot study of atrial fibrillation patients on which he is co-supervisor

Before You Book

  • Confirm the clinic. Executive Health consults from Stockholm, Lund and Marbella, and no single site is fixed to him, so ask which one he works from.
  • Match the question to his scope. Heart rhythm, vascular and general internal medicine. Reading the scans sits with the radiologists, and orthopedics and psychiatry with other doctors.
  • Name him at the request stage. Screening is booked by program rather than by doctor, so say so if you want him.

Verification

Profile updated
Credentials checked
Affiliations verified

Primary sourcehttps://www.executive-health.com/doctors/david-waldenhjort

Where a detail is missing, it means we have not verified it—not that the answer is no. Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.